Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1

Integase interactor 1 (INI1), also known as hSNF5, is a protein that interacts with HIV-1 integrase. We report here that a cytoplasmically localized fragment of INI1 (S6; aa183–294) containing the minimal integrase-interaction domain potently inhibits HIV-1 particle production and replication. Mutations in S6 or integrase that disrupt integrase–INI1 interaction abrogated the inhibitory effect. An integrase-deficient HIV-1 transcomplemented with integrase fused to Vpr was not affected by S6. INI1 was specifically incorporated into virions and was required for efficient HIV-1 particle production. These results indicate that INI1 is required for late events in the viral life cycle, and that ectopic expression of S6 inhibits HIV-1 replication in a transdominant manner via its specific interaction with integrase within the context of Gag–Pol, providing a novel strategy to control HIV-1 replication.

[1]  D. Goeddel,et al.  A method for random mutagenesis of a defined DNA segment using a modified polymerase chain reaction , 1989 .

[2]  P. Brown,et al.  Integration of retroviral DNA. , 1990, Current topics in microbiology and immunology.

[3]  M. Stevenson,et al.  HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.

[4]  A. Kingsman,et al.  Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues , 1994, Journal of virology.

[5]  A. Skalka,et al.  Molecular mechanism of retroviral DNA integration. , 1994, Pharmacology & therapeutics.

[6]  G. Crabtree,et al.  Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. , 1994, Science.

[7]  C. Sardet,et al.  A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. , 1995, Nucleic acids research.

[8]  F. Bushman,et al.  HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase , 1995, Cell.

[9]  T. Masuda,et al.  Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain , 1995, Journal of virology.

[10]  R. Gibbs,et al.  Analysis of human immunodeficiency virus type 1 integrase mutants. , 1995, Virology.

[11]  A. Engelman,et al.  Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication , 1995, Journal of virology.

[12]  M. Muesing,et al.  Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells , 1995, Journal of virology.

[13]  H. Göttlinger,et al.  Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease , 1996, Journal of virology.

[14]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[15]  H. Varmus,et al.  Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection , 1996, Journal of virology.

[16]  M. Yaniv,et al.  Purification and biochemical heterogeneity of the mammalian SWI‐SNF complex. , 1996, The EMBO journal.

[17]  L. Arthur,et al.  Cytoskeletal proteins inside human immunodeficiency virus type 1 virions , 1996, Journal of virology.

[18]  J. Boeke,et al.  Complementation of integrase function in HIV‐1 virions , 1997, The EMBO journal.

[19]  E. Asante-Appiah,et al.  Molecular mechanisms in retrovirus DNA integration. , 1997, Antiviral research.

[20]  T. Masuda,et al.  Lack of infectivity of HIV-1 integrase zinc finger-like domain mutant with morphologically normal maturation. , 1997, Biochemical and biophysical research communications.

[21]  R. Swanstrom,et al.  Synthesis, Assembly, and Processing of Viral Proteins , 1997 .

[22]  J. Kappes,et al.  Functional RT and IN incorporated into HIV‐1 particles independently of the Gag/Pol precursor protein , 1997, The EMBO journal.

[23]  G. Kalpana,et al.  Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Olivier Delattre,et al.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.

[25]  S. G. Cheng,et al.  c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function , 1999, Nature Genetics.

[26]  J. Biegel,et al.  Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. , 1999, Cancer research.

[27]  R. Desrosiers.  Strategies used by human immunodeficiency virus that allow persistent viral replication , 1999, Nature Medicine.

[28]  Y. Pommier,et al.  Inhibitors of human immunodeficiency virus integrase. , 1999, Advances in virus research.

[29]  R. Kingston,et al.  ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. , 1999, Genes & development.

[30]  J. Kappes,et al.  Human Immunodeficiency Virus Type 1 Integrase Protein Promotes Reverse Transcription through Specific Interactions with the Nucleoprotein Reverse Transcription Complex , 1999, Journal of Virology.

[31]  V. Nair,et al.  Potential inhibitors of HIV integrase. , 1999, Nucleosides & nucleotides.

[32]  A. Pani,et al.  Anti-HIV-1 integrase drugs: how far from the shelf? , 2000, Current pharmaceutical design.